A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira® Lung Denervation System in Subjects with Chronic Obstructive Pulmonary Disease (COPD) (AIRFLOW-3)

The purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System (Nuvaira System) in the treatment of COPD.

Study-ID: NCT03639051

DZL Disease Area: COPD

Study Type: Interventional

DZL Role: DZL recruiting center

Funding: Externally - industry

DZL Participating Sites: TLRC;

Start Date: 23.05.2019

Completion Date: 27.03.2025

Status: Closed

Disease: COPD

NCT Number: NCT03639051